Cargando…

The mechanisms of action of ivermectin against SARS-CoV-2—an extensive review

Considering the urgency of the ongoing COVID-19 pandemic, detection of new mutant strains and potential re-emergence of novel coronaviruses, repurposing of drugs such as ivermectin could be worthy of attention. This review article aims to discuss the probable mechanisms of action of ivermectin again...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zaidi, Asiya Kamber, Dehgani-Mobaraki, Puya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688140/ https://www.ncbi.nlm.nih.gov/pubmed/34931048 http://dx.doi.org/10.1038/s41429-021-00491-6

Ejemplares similares

RETRACTED ARTICLE: The mechanisms of action of Ivermectin against SARS-CoV-2: An evidence-based clinical review article
por: Zaidi, Asiya Kamber, et al.
Publicado: (2021)

Longitudinal observation of antibody responses for 14 months after SARS-CoV-2 infection
por: Dehgani-Mobaraki, Puya, et al.
Publicado: (2021)

Coexistence of proboscis lateralis and multiple craniofacial, neurological, cardiac and spinal deformities: a one-of-a-kind case report
por: Zaidi, Asiya Kamber, et al.
Publicado: (2023)

Long-term persistence of IgG antibodies in recovered COVID-19 individuals at 18 months post-infection and the impact of two-dose BNT162b2 (Pfizer-BioNTech) mRNA vaccination on the antibody response: Analysis using fixed-effects linear regression model
por: Dehgani-Mobaraki, Puya, et al.
Publicado: (2023)

Prospective mode of action of Ivermectin: SARS-CoV-2
por: Patil, Vaishali M., et al.
Publicado: (2022)

Repositioning Ivermectin for Covid-19 treatment: Molecular mechanisms of action against SARS-CoV-2 replication
por: Low, Zheng Yao, et al.
Publicado: (2022)

The binding mechanism of ivermectin and levosalbutamol with spike protein of SARS-CoV-2
por: Saha, Joyanta Kumar, et al.
Publicado: (2021)

Residual Dizziness after Successful Repositioning Maneuver for Idiopathic Benign Paroxysmal Positional Vertigo: A Review
por: Giommetti, Giorgia, et al.
Publicado: (2017)

Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19
por: Sharun, Khan, et al.
Publicado: (2020)

Ivermectin Does Not Protect against SARS-CoV-2 Infection in the Syrian Hamster Model
por: Foo, Caroline S., et al.
Publicado: (2022)

Molecular Docking Reveals Ivermectin and Remdesivir as Potential Repurposed Drugs Against SARS-CoV-2
por: Eweas, Ahmad F., et al.
Publicado: (2021)

Potential use of ivermectin for the treatment and prophylaxis of SARS-CoV-2 infection
por: Cobos-Campos, R, et al.
Publicado: (2021)

In Vitro Analysis of SARS-CoV-2 Spike Protein and Ivermectin Interaction
por: García-Aguilar, Alejandra, et al.
Publicado: (2023)

Exploring the binding efficacy of ivermectin against the key proteins of SARS-CoV-2 pathogenesis: an in silico approach
por: Choudhury, Abhigyan, et al.
Publicado: (2021)

Remdesivir–ivermectin combination displays synergistic interaction with improved in vitro activity against SARS-CoV-2
por: Jeffreys, Laura N., et al.
Publicado: (2022)

The broad spectrum host-directed agent ivermectin as an antiviral for SARS-CoV-2 ?
por: Jans, David A., et al.
Publicado: (2021)

The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
por: Caly, Leon, et al.
Publicado: (2020)

Attenuation of clinical and immunological outcomes during SARS‐CoV‐2 infection by ivermectin
por: de Melo, Guilherme Dias, et al.
Publicado: (2021)

Hydroxychloroquine in COVID-19: Potential Mechanism of Action Against SARS-CoV-2
por: Satarker, Sairaj, et al.
Publicado: (2020)

Mechanism of action of favipiravir against SARS-CoV-2: Mutagenesis or chain termination?
por: Zhao, Lei, et al.
Publicado: (2021)

A dual mechanism of action of AT-527 against SARS-CoV-2 polymerase
por: Shannon, Ashleigh, et al.
Publicado: (2022)

Virucidal activity and mechanism of action of cetylpyridinium chloride against SARS-CoV-2
por: Okamoto, Nako, et al.
Publicado: (2022)

Drug targets, mechanisms of drug action, and therapeutics against SARS-CoV-2
por: Jena, N.R.
Publicado: (2021)

Retracted: Meta-analysis of Randomized Trials of Ivermectin to Treat SARS-CoV-2 Infection
por: Hill, Andrew, et al.
Publicado: (2021)

Retraction to: Meta-analysis of Randomized Trials of Ivermectin to Treat SARS-CoV-2 Infection
por: Hill, Andrew, et al.
Publicado: (2022)

Nonspecific membrane bilayer perturbations by ivermectin underlie SARS-CoV-2 in vitro activity
por: Eastman, Richard T., et al.
Publicado: (2023)

Results of a systematic review and meta-analysis of early studies on ivermectin in SARS-CoV-2 infection
por: Ragó, Zsuzsanna, et al.
Publicado: (2023)

Actions and attitudes on the immunized patients against SARS-CoV-2
por: Ramos, Pilar De Lucas, et al.
Publicado: (2021)

Antiviral Activity of Repurposing Ivermectin against a Panel of 30 Clinical SARS-CoV-2 Strains Belonging to 14 Variants
por: Delandre, Océane, et al.
Publicado: (2022)

Kill or corrupt: Mechanisms of action and drug-resistance of nucleotide analogues against SARS-CoV-2
por: Shannon, Ashleigh, et al.
Publicado: (2023)

Hydroxychloroquine: mechanism of action inhibiting SARS-CoV2 entry.
por: Yuan, Zixuan, et al.
Publicado: (2020)

Editorial: The Mechanisms of Action of Anti-SARS-CoV-2 Drugs
por: Zhong, Wu, et al.
Publicado: (2022)

Insights into the SARS-CoV-2 ORF6 Mechanism of Action
por: Krachmarova, Elena, et al.
Publicado: (2023)

RETRACTED: Expression of Concern: “Meta-analysis of Randomized Trials of Ivermectin to Treat SARS-CoV-2 Infection”
por: Hill, Andrew, et al.
Publicado: (2021)

Prophylactic administration of ivermectin attenuates SARS-CoV-2 induced disease in a Syrian Hamster Model
por: Uematsu, Takayuki, et al.
Publicado: (2023)

Family clustering of SARS-CoV-2 in Qazvin, Northwest of Iran
por: Hosseinkhani, Zahra, et al.
Publicado: (2022)

In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection
por: Braz, Helyson Lucas Bezerra, et al.
Publicado: (2020)

Enoxaparin’s potential mechanisms against SARS-CoV-2
por: Afsharirad, Bentelhoda, et al.
Publicado: (2023)

Smell and taste dysfunction in patients with COVID-19
por: Xydakis, Michael S, et al.
Publicado: (2020)

Drug repurposing against SARS-CoV-1, SARS-CoV-2 and MERS-CoV
por: Aherfi, Sarah, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9h5p53bkd4cfbcni2av0br8770